Industry News

Cancer Research U.K., Cancer Research Technology ink agreement with Astellas

Centerwatch - Mon, 2014-08-11 09:35
Cancer Research U.K. and its commercial arm, Cancer Research Technology (CRT), have joined with Astellas Pharma to conduct a two-year research program in the U.K. to find new drug targets in the fight against cancer, with an initial focus on pancreatic cancer.
Categories: Industry News

Written Requests Issued

FDA News - Mon, 2014-08-11 07:52
Updated list of approved active moieties to which FDA has issued a Written Request for pediatric studies
Categories: Industry News

The Pulse on Site Success

Centerwatch - Mon, 2014-08-11 03:00
For many years, Research Across America (RAA) has owned a mobile van affectionately known as “Barney” because of its color, purple!
Categories: Industry News

Cranial Electrical Stimulation Effects on Symptoms in Persons With Fibromyalgia

sleep - Sun, 2014-08-10 20:00
Status: Completed, Condition Summary: Fibromyalgia
Categories: Industry News

Sleep Specialty Consultation: Improving Management of Sleep Disorders

sleep - Sun, 2014-08-10 20:00
Status: Completed, Condition Summary: Sleep Disorders
Categories: Industry News

Pediatric Exclusivity Statistics

FDA News - Fri, 2014-08-08 13:14
Updated list.
Categories: Industry News

YourEncore launches regulatory center of excellence

Centerwatch - Fri, 2014-08-08 09:12
YourEncore, which helps life sciences, consumer products and food companies solve complex innovation, compliance and productivity challenges, has launched the Regulatory Center of Excellence, to provide life sciences companies with industry-accomplished experts to guide them through complex regulatory requirements, from phase I trials through approval.
Categories: Industry News

ACRP, IAOCR collaborate on combined program suites

Centerwatch - Fri, 2014-08-08 09:10
The Association of Clinical Research Professionals (ACRP) and the U.K.-based International Academy of Clinical Research (IAoCR), provider of accreditation, training and consultancy for clinical researchers, are collaborating to offer services and establish recognized global standards of clinical research.
Categories: Industry News

Igenica Biotherapeutics awarded SBIR grant for antibody drug conjugate technology

Centerwatch - Fri, 2014-08-08 09:09
Igenica Biotherapeutics, focused on the discovery and development of innovative cancer antibody-drug conjugates (ADCs), has been awarded a $215,740 Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI) to support continued development of its SNAP site-specific ADC linker technology.
Categories: Industry News

FDA approves Orbactiv to treat skin infections

Centerwatch - Fri, 2014-08-08 08:44
The FDA has approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections.
Categories: Industry News

BioSpecifics Technologies initiates phase II study of CCH for Lipoma

Centerwatch - Fri, 2014-08-08 08:33
BioSpecifics Technologies, a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX in the E.U., has injected the first patient in its placebo-controlled phase II clinical trial of CCH for the treatment of lipoma. The company expects to complete patient enrollment in this trial during the first quarter of 2015.
Categories: Industry News

Theravance appoints Michael W. Aguiar as president, CEO

Centerwatch - Fri, 2014-08-08 08:29
Theravance has appointed Michael W. Aguiar as president and CEO effective August 15, and as a member of the board of directors effective immediately. Aguiar plans to continue to as Theravance's senior vice president and chief financial officer until his replacement is identified and appointed. 
Categories: Industry News

Wed, 1969-12-31 20:00
Syndicate content